Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50
WRAC.WS
WRAC.WS was delisted on the 13th of June, 2023.
32 hedge funds and large institutions have $3.21M invested in Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
7% more funds holding
Funds holding: 30 → 32 (+2)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
52% less capital invested
Capital invested by funds: $6.74M → $3.21M (-$3.53M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Ramius Advisors
New York
|
+$137K |
| 2 |
FBCM
Fort Baker Capital Management
Larkspur,
California
|
+$86.1K |
| 3 |
CS
Clear Street
New York
|
+$59K |
| 4 |
CAC
Cowen and Company
New York
|
+$13.2K |
| 5 |
AGM
Alpine Global Management
New York
|
+$11.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$1.99M |
| 2 |
QGA
Q Global Advisors
Fort Worth,
Texas
|
-$59K |
| 3 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$1.35K |
| 4 |
Walleye Capital
New York
|
-$24 |
| 5 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
-$22 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Walleye Trading
New York
| $5K | – | – | – |
|
|
AGM
27
Alpine Global Management
New York
| $5K | +$11.6K | +53,800 | New |
|
|
AC
28
Antara Capital
New York
| $4K | – | – | – |
|
29
Balyasny Asset Management
Chicago,
Illinois
| $4K | – | – | – |
|
|
PCM
30
Prelude Capital Management
New York
| $4K | – | – | – |
|
|
RCM
31
Rivernorth Capital Management
West Palm Beach,
Florida
| $4K | – | – | – |
|
32
Capstone Investment Advisors
New York
| $3K | – | – | – |
|
|
OCAM
33
Owl Creek Asset Management
New York
| $2K | – | – | – |
|
|
MF
34
Magnetar Financial
Evanston,
Illinois
| $3 | +$8K | +37,215 | New |
|
|
QGA
35
Q Global Advisors
Fort Worth,
Texas
| – | -$59K | -225,000 | Closed |
|
|
MP
36
Mangrove Partners
Greenwich,
Connecticut
| – | -$1.99M | -200,000 | Closed |
|
WRAC.WS Hedge Fund Activity: Q2 2022 in Review
32 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 (WRAC.WS) for Q2 2022, worth a combined $3.21M — down 52% from $6.74M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new WRAC.WS positions and 2 closed out — a net gain of 2 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Ramius Advisors, opening a new position worth an estimated $137K. The largest seller was Mangrove Partners, exiting entirely with an estimated $1.99M sold.
- 32 institutional investors held Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 (WRAC.WS) as of Q2 2022, up from 30 in Q1 2022.
- Funds reported $3.21M of Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 stock for Q2 2022, down 52% quarter-over-quarter.
- 4 funds opened new Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 positions in Q2 2022 and 2 closed out, a net change of +2 holders.
- The largest Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 buyer in Q2 2022 was Ramius Advisors, an estimated $137K added.
- The largest Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 seller in Q2 2022 was Mangrove Partners, an estimated $1.99M sold.
Based on aggregated 13F filings for Q2 2022.